Status:
COMPLETED
SARS-CoV2 (COVID-19) Diagnosis in Human Saliva by MALDI-TOF MS Profiling
Lead Sponsor:
Direction Centrale du Service de Santé des Armées
Conditions:
SARS-CoV 2
Eligibility:
All Genders
18+ years
Brief Summary
Since March 2020, SARS-CoV2 virus (nCoV19; COVID-19) is considered pandemic. Its high rate of spread and infection in the human population and the lack of effective and validated treatment have led th...
Eligibility Criteria
Inclusion
- 18 years of age;
- screened for SARS-CoV2 by RT-PCR from a nasopharyngeal swab within 96 hours prior to inclusion.
Exclusion
- Patient admitted to intensive care;
- Pregnant woman.
Key Trial Info
Start Date :
July 23 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 13 2021
Estimated Enrollment :
779 Patients enrolled
Trial Details
Trial ID
NCT04460638
Start Date
July 23 2020
End Date
August 13 2021
Last Update
September 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital d'Instruction des Armées Laveran
Marseille, France, 13013